ATRENEW INC(NYSE:RERE) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, RERE scores 5 out of 10 in our fundamental rating. RERE was compared to 120 industry peers in the Specialty Retail industry. While RERE has a great health rating, there are worries on its profitability. RERE shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

RERE had negative earnings in the past year.

In the past year RERE had a positive cash flow from operations.

RERE had negative earnings in each of the past 5 years.

In multiple years RERE reported negative operating cash flow during the last 5 years.

1.2 Ratios

RERE has a Return On Assets (-0.18%) which is comparable to the rest of the industry.

RERE's Return On Equity of -0.24% is in line compared to the rest of the industry. RERE outperforms 51.24% of its industry peers.

Looking at the Return On Invested Capital, with a value of 0.61%, RERE is doing worse than 61.98% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-0.18%
ROE	-0.24%
ROIC	0.61%

ROA(3y)-17.29%

ROA(5y)-20.7%

ROE(3y)-22.67%

ROE(5y)-27.41%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 0.18%, RERE is not doing good in the industry: 63.64% of the companies in the same industry are doing better.

With a Gross Margin value of 11.39%, RERE is not doing good in the industry: 93.39% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of RERE has grown nicely.

		Industry Rank	Sector Rank
OM	0.18%
PM (TTM)	N/A
GM	11.39%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.4%

GM growth 5Y35.7%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RERE is destroying value.

Compared to 1 year ago, RERE has less shares outstanding

Compared to 5 years ago, RERE has about the same amount of shares outstanding.

The debt/assets ratio for RERE has been reduced compared to a year ago.

2.2 Solvency

RERE has an Altman-Z score of 3.17. This indicates that RERE is financially healthy and has little risk of bankruptcy at the moment.

With a decent Altman-Z score value of 3.17, RERE is doing good in the industry, outperforming 74.38% of the companies in the same industry.

RERE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.39
Altman-Z	3.17

ROIC/WACC0.07

WACC8.21%

2.3 Liquidity

A Current Ratio of 3.19 indicates that RERE has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 3.19, RERE belongs to the top of the industry, outperforming 93.39% of the companies in the same industry.

A Quick Ratio of 2.78 indicates that RERE has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 2.78, RERE belongs to the top of the industry, outperforming 96.69% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.19
Quick Ratio	2.78

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

RERE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.81%, which is quite impressive.

Looking at the last year, RERE shows a very strong growth in Revenue. The Revenue has grown by 25.93%.

Measured over the past years, RERE shows a very strong growth in Revenue. The Revenue has been growing by 32.94% on average per year.

EPS 1Y (TTM)94.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%2300%

Revenue 1Y (TTM)25.93%

Revenue growth 3Y28.03%

Revenue growth 5Y32.94%

Sales Q2Q%25.18%

3.2 Future

Based on estimates for the next years, RERE will show a very strong growth in Earnings Per Share. The EPS will grow by 50.92% on average per year.

The Revenue is expected to grow by 25.90% on average over the next years. This is a very strong growth

EPS Next Y50%

EPS Next 2Y50.92%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year27.39%

Revenue Next 2Y25.9%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

RERE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

With a Price/Forward Earnings ratio of 68.35, RERE can be considered very expensive at the moment.

RERE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. RERE is more expensive than 63.64% of the companies in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 21.77, RERE is valued quite expensively.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	68.35

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as RERE.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of RERE indicates a rather cheap valuation: RERE is cheaper than 88.43% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	7.16
EV/EBITDA	14.84

4.3 Compensation for Growth

RERE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

RERE's earnings are expected to grow with 50.92% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y50.92%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

RERE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ATRENEW INC

NYSE:RERE (5/23/2025, 8:51:56 PM)

After market: 2.62 0 (0%)

2.62

-0.05 (-1.87%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)05-20 2025-05-20/bmo

Earnings (Next)08-18 2025-08-18

Inst Owners36.15%

Inst Owner Change4.26%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap580.86M

Analysts85.71

Price Target5.1 (94.66%)

Short Float %1.19%

Short Ratio2.17

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-1.07%

Min Revenue beat(2)-1.14%

Max Revenue beat(2)-1%

Revenue beat(4)1

Avg Revenue beat(4)-0.52%

Min Revenue beat(4)-1.14%

Max Revenue beat(4)0.5%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)58.73%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-18.18%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)1.87%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	68.35
P/S	0.26
P/FCF	7.16
P/OCF	6.49
P/B	1.13
P/tB	1.15
EV/EBITDA	14.84

EPS(TTM)-0.01

EYN/A

EPS(NY)0.04

Fwd EY1.46%

FCF(TTM)0.37

FCFY13.97%

OCF(TTM)0.4

OCFY15.41%

SpS10.25

BVpS2.32

TBVpS2.28

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.18%
ROE	-0.24%
ROCE	0.78%
ROIC	0.61%
ROICexc	0.61%
ROICexgc	0.62%
OM	0.18%
PM (TTM)	N/A
GM	11.39%
FCFM	3.57%

ROA(3y)-17.29%

ROA(5y)-20.7%

ROE(3y)-22.67%

ROE(5y)-27.41%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.4%

GM growth 5Y35.7%

F-Score7

Asset Turnover3.21

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.39
Debt/EBITDA	0
Cap/Depr	22.47%
Cap/Sales	0.37%
Interest Coverage	1.96
Cash Conversion	216.96%
Profit Quality	N/A
Current Ratio	3.19
Quick Ratio	2.78
Altman-Z	3.17

F-Score7

WACC8.21%

ROIC/WACC0.07

Cap/Depr(3y)21.03%

Cap/Depr(5y)18.67%

Cap/Sales(3y)0.55%

Cap/Sales(5y)0.67%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)94.81%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%2300%

EPS Next Y50%

EPS Next 2Y50.92%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)25.93%

Revenue growth 3Y28.03%

Revenue growth 5Y32.94%

Sales Q2Q%25.18%

Revenue Next Year27.39%

Revenue Next 2Y25.9%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y116.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year39.3%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y266.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y163.53%

OCF growth 3YN/A

OCF growth 5YN/A

ATRENEW INC (RERE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens